Vacci-Test has announced that its French subsidiary, Vacci-Test Europe, has launched its first human diagnostic test, Vacci-Test-Tetanus in France and Germany.
Subscribe to our email newsletter
Vacci-Test-Tetanus is a rapid, sensitive, lateral flow diagnostic assay that determines the immune status of an individual by detecting the presence of circulating antibodies.
The Vacci-Test-Tetanus is being distributed by Groupe ServioBio, one of Europe’s distributors of point-of-care diagnostic tests to hospitals and emergency clinics.
Bernard Boyer, managing director of Vacci-Test, said: “We are confident that our new product will become the assay of choice as a rapid, reliable point-of-care tetanus test and will avoid the need and expense of unnecessary revaccination.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.